Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J. Nutt

Showing results (161-170 of 329) with videos related to

Pageof 33
Sort By:
The Journal of Clinical Psychiatry|February 10, 2007
Consensus statement on the benefit to the community of ESEMeD (European Study of the Epidemiology of Mental Disorders) survey data on depression and anxietyDavid J Nutt, Ronald C Kessler, Jordi Alonso, et al.
Addiction (Abingdon, England)|June 25, 2016
Behavioural tasks sensitive to acute abstinence and predictive of smoking cessation success: a systematic review and meta-analysisMeryem Grabski, H Valerie Curran, David J Nutt, et al.
Psychopharmacology|November 26, 2009
Effects of acute tryptophan depletion in serotonin reuptake inhibitor-remitted patients with generalized anxiety disorderSean D Hood, Dana A Hince, Simon J C Davies, et al.
Expert Reviews in Molecular Medicine|September 1, 2006
Tryptophan metabolism in the central nervous system: medical implicationsJon P Ruddick, Andrew K Evans, David J Nutt, et al.
Human Psychopharmacology|October 3, 2012
The effect of a clinically effective and non-effective dose of lorazepam on 7.5% CO₂-induced anxietyAlison Diaper, Andreas Papadopoulos, Ann S Rich, et al.
Journal of Affective Disorders|February 7, 2018
Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depressionFacundo Carrillo, Mariano Sigman, Diego Fernández Slezak, et al.
Bjpsych Open|January 20, 2022
Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic reviewZach Walsh, Ozden Merve Mollaahmetoglu, Joseph Rootman, et al.
CNS Spectrums|February 10, 2004
WCA Recommendations for the long-term treatment of posttraumatic stress disorderDan J Stein, Borwin Bandelow, Eric Hollander, et al.
Journal of Sleep Research|June 25, 2009
Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodoneSpilios V Argyropoulos, Jane A Hicks, John R Nash, et al.
Pharmacological Reviews|September 26, 2015
Mechanisms of Action and Persistent Neuroplasticity by Drugs of AbuseEsa R Korpi, Bjørnar den Hollander, Usman Farooq, et al.
Pageof 33

Showing results (161-170 of 329) with videos related to

Sort By:
Pageof 33
The Journal of Clinical Psychiatry|February 10, 2007
Consensus statement on the benefit to the community of ESEMeD (European Study of the Epidemiology of Mental Disorders) survey data on depression and anxietyDavid J Nutt, Ronald C Kessler, Jordi Alonso, et al.
Addiction (Abingdon, England)|June 25, 2016
Behavioural tasks sensitive to acute abstinence and predictive of smoking cessation success: a systematic review and meta-analysisMeryem Grabski, H Valerie Curran, David J Nutt, et al.
Psychopharmacology|November 26, 2009
Effects of acute tryptophan depletion in serotonin reuptake inhibitor-remitted patients with generalized anxiety disorderSean D Hood, Dana A Hince, Simon J C Davies, et al.
Expert Reviews in Molecular Medicine|September 1, 2006
Tryptophan metabolism in the central nervous system: medical implicationsJon P Ruddick, Andrew K Evans, David J Nutt, et al.
Human Psychopharmacology|October 3, 2012
The effect of a clinically effective and non-effective dose of lorazepam on 7.5% CO₂-induced anxietyAlison Diaper, Andreas Papadopoulos, Ann S Rich, et al.
Journal of Affective Disorders|February 7, 2018
Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depressionFacundo Carrillo, Mariano Sigman, Diego Fernández Slezak, et al.
Bjpsych Open|January 20, 2022
Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic reviewZach Walsh, Ozden Merve Mollaahmetoglu, Joseph Rootman, et al.
CNS Spectrums|February 10, 2004
WCA Recommendations for the long-term treatment of posttraumatic stress disorderDan J Stein, Borwin Bandelow, Eric Hollander, et al.
Journal of Sleep Research|June 25, 2009
Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodoneSpilios V Argyropoulos, Jane A Hicks, John R Nash, et al.
Pharmacological Reviews|September 26, 2015
Mechanisms of Action and Persistent Neuroplasticity by Drugs of AbuseEsa R Korpi, Bjørnar den Hollander, Usman Farooq, et al.
Pageof 33